Login     Register  
    Home   |   Search   |   Director's Bio   |   About/Contact Us   |   Disclaimer  
BioEndeavor - Empowering Women  
 Home
 About BioEndeavor
 Engaged Thinking
 Engaged Thinking Blog
 Engaged Innovation Case Studies
 Engaged Thinking Academy
 Resources
 Engaged Innovation Directory
 Capacity Development
Neglected Tropical Diseases 
Non-Communicable Diseases 

Drug Discovery 
Preclinical 
Clinical 
Healthcare 
 Add Organization 


Drug Discovery
GlaxoSmithKline's Tres Cantos Open LabGo Back  
Organization URL

Organization:
GlaxoSmithKline's Tres Cantos Open Lab

Year Established: 2001

Profile:
GlaxoSmithKline has an R&D facility in Tres Cantos, Spain, which has been dedicated to developing new treatments to combat diseases of the developing world (DDW) since it was established in 2001. Since that time, GSK has worked in a number of Public Private Partnerships (PPPs) with more than 100 scientists at the site partly funded by GSK's partners. In 2009, GSK announced its intention to open up the Tres Cantos facility further, to become a global centre of excellence that brings new partners to the facility and stimulates research and collaboration on neglected diseases where research is still too fragmented.

GSK’s open laboratory has space for visiting scientists from universities, not-for-profit partnerships and other research institutes - such as the Barcelona Centre for International Health Research (CRESIB), Weill Cornell Medical College in the US, and Imperial College, London - to work on their projects for the developing world, learn from our expertise and share our world-class facilities.


Target Sector:
Drug Discovery

Typology of Knowledge Network:
Public-Private Partnership (PPP)

Knowledge Type / Focus:
Data
Biological Tools
Biological Materials
Biological Technology
Health Products

Participant Type:
Non-Profit
Private Sector

Objective / Knowledge Governance:
Cooperative Research


© 2010-2017 BioEndeavor.Net
Privacy and Security Statement Disclaimer Adding Directory Profiles